Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Share-based Compensation (2025 - 2026)

Updated

Nervgen Pharma (NGEN) reported Share-based Compensation of $1.98 million for Q2 2026, up 35.8% from $1.46 million a year earlier and up 184.9% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Share-based Compensation (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nervgen Pharma's Share-based Compensation came in at $5.15 million; for FY2025, it was $2.58 million, down 22.0% from FY2024.

  • By year, Share-based Compensation came in at $3.31 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 357.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 160.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 234.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 362.00 Mn
10 Nervgen Pharma 105.93 Mn 4.82 Mn - 1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.98 Mn
Mar 31, 2026 694,299.34
Jun 30, 2025 1.46 Mn
Mar 31, 2025 1.02 Mn
API Access

Nervgen Pharma Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NGEN&period=max&api_key=YOUR_API_KEY